Log In
Print
BCIQ
Print
Print this Print this
 

AFM11

  Manage Alerts
Collapse Summary General Information
Company Affimed Therapeutics B.V.
DescriptionTetravalent bispecific human antibody targeting CD19 and CD3
Molecular Target CD19 ; CD3
Mechanism of ActionBinds CD19; Binds CD3
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationNon-Hodgkin's lymphoma (NHL)
Indication DetailsTreat non-Hodgkin's lymphoma (NHL)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today